Le Foll Bernard, Goldberg Steven R
Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, University of Toronto, 33 Russell Street, Toronto, ON, M5S 2S1, Canada.
Handb Exp Pharmacol. 2009(192):335-67. doi: 10.1007/978-3-540-69248-5_12.
Tobacco use through cigarette smoking is the leading preventable cause of death in the developed world. Nicotine, a psychoactive component of tobacco, appears to play a major role in tobacco dependence, but the reinforcing effects of nicotine have often been difficult to demonstrate directly in controlled studies with laboratory animals or human subjects. Here we update our earlier review published in Psychopharmacology (Berl) in 2006 on findings obtained with various procedures developed to study dependence-related behavioral effects of nicotine in experimental animals and humans. Results obtained with drug self-administration, conditioned place preference, subjective reports of nicotine effects and nicotine discrimination indicate that nicotine can function as an effective reinforcer of drug-seeking and drug-taking behavior both in experimental animals and humans under appropriate conditions. Interruption of chronic nicotine exposure produces ratings of drug withdrawal and withdrawal symptoms that may contribute to relapse. Difficulties encountered in demonstrating reinforcing effects of nicotine under some conditions, relative to other drugs of abuse, may be due to weaker primary reinforcing effects of nicotine, to aversive effects produced by nicotine, or to a more critical contribution of environmental stimuli to the maintenance of drug-seeking and drug-taking behavior with nicotine than with other drugs of abuse. Several recent reports suggest that other chemical substances inhaled along with nicotine in tobacco smoke may play a role in sustaining smoking behavior. However, conflicting results have been obtained with mice and rats and these findings have not yet been validated in nonhuman primates or human subjects. Taken together, these findings suggest that nicotine acts as a typical drug of abuse in experimental animals and humans in appropriate situations.
在发达国家,吸烟是可预防的首要死亡原因。尼古丁作为烟草中的一种精神活性成分,似乎在烟草依赖中起主要作用,但在实验室动物或人类受试者的对照研究中,尼古丁的强化作用往往难以直接证明。在此,我们更新了2006年发表于《精神药理学(柏林)》上的早期综述,内容涉及为研究尼古丁在实验动物和人类中与依赖相关的行为效应而开发的各种程序所获得的研究结果。药物自我给药、条件性位置偏爱、尼古丁效应的主观报告以及尼古丁辨别实验所获得的结果表明,在适当条件下,尼古丁在实验动物和人类中均可作为寻求药物和用药行为的有效强化物。长期尼古丁暴露的中断会产生药物戒断评分和戒断症状,这可能会导致复吸。与其他滥用药物相比,在某些条件下证明尼古丁强化作用时遇到的困难,可能是由于尼古丁的主要强化作用较弱、尼古丁产生的厌恶效应,或者是环境刺激对维持尼古丁寻求药物和用药行为的贡献比其他滥用药物更为关键。最近的几份报告表明,烟草烟雾中与尼古丁一起吸入的其他化学物质可能在维持吸烟行为中起作用。然而,在小鼠和大鼠身上得到了相互矛盾的结果,这些发现尚未在非人类灵长类动物或人类受试者中得到验证。综上所述,这些发现表明,在适当情况下,尼古丁在实验动物和人类中表现为一种典型的滥用药物。